Theravia

News

Netherlands-based pharma group Norgine has expanded its rare disease portfolio with the acquisition of France's Theravia for an undisclosed sum.

News

Pfizer has upped the ante in the increasingly competitive market for pneumococcal vaccines with new data on a 25-valent candidate.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.